Clinical Trial Update: Efficacy and Safety of Bupropion for Treatment of Adolescent Smoking [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluates the efficacy and safety of bupropion for treating adolescent tobacco dependence; the study status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tobacco Dependence

Drugs mentioned

• bupropion (bupropion)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Tobacco Dependence | Phase 2, Phase 3 | Status: TERMINATED